1. Tissier H. Recherches sur la flore intestinale des nourrissons (état normal et pathologique). University of Paris. 1900.
2. Metchnikoff I. The Prolongation of Life: Optimistic Studies (Classics in Longevity and Aging). 1907.
3. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147:747–8.
4. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–78.
5. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. 1-4 October 2001.
6. Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 30 April - 1 May 2002.
7. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.
8. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, Sherman PM, Mayer EA. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62:787–96.
9. Jäger R, Mohr AE, Carpenter KC, Kerksick CM, Purpura M, Moussa A, Townsend JR, Lamprecht M, West NP, Black K, Gleeson M, Pyne DB, Wells SD, Arent SM, Smith-Ryan AE, Kreider RB, Campbell BI, Bannock L, Scheiman J, Wissent CJ, Pane M, Kalman DS, Pugh JN, Ter Haar JA, Antonio J. International Society of Sports Nutrition Position Stand: Probiotics. J Int Soc Sports Nutr. 2019;16:62.
10. Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A Review on role of microbiome in obesity and antiobesity properties of probiotic supplements. Biomed Res Int. 2019;2019:3291367.
11. Yakult Central Institute for Microbiological Research. Lactobacillus casei strain Shirota : intestinal microbiota and human health: new advances. 2013.
12. Yuki N, Watanabe K, Mike A, Tagami Y, Tanaka R, Ohwaki M, Morotomi M. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int J Food Microbiol. 1999;48:51–7.
13. Matsumoto K, Takada T, Shimizu K, Kado Y, Kawakami K, Makino I, Yamaoka Y, Hirano K, Nishimura A, Kajimoto O, Nomoto K. The Effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers : a randomized placebo-controlled cross-over study. Biocsi Microflora. 2006;25:39–48.
14. Shioiri T, Yahagi K, Nakayama S, Asahara T, Yuki N, Kawakami K, Yamaoka Y, Sakai Y, Nomoto K, Totani M. The effect of a symbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora. 2006;25:137–46.
15. Shida K, Suzuki T, Kiyoshima-Shibata J, Shimada S, Nanno M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol. 2006;13:997–1003.
16. Shida K, Kiyoshima-Shibata J, Nagaoka M, Watanabe K, Nanno M. Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J Dairy Sci. 2006;89:3306–17.
17. Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000;64:2706–8.
18. Morimoto K, Takeshita T, Nanno M, Tokudome S, Nakayama K. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev Med. 2005;40:589–94.
19. Takeda K, Suzuki T, Shimada S-I, Shida K, Nanno M, Okumura K. Interleukin- 12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol. 2006;146:109–15.
20. Shida K, Sato T, Iizuka R, Hoshi R, Watanabe O, Igarashi T, Miyazaki K, Nanno M, Ishikawa F. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. Eur J Nutr. 2017;56:45–53.
21. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, Ishiguro S, Miyaoka E, Sobue T, Kakizoe T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005;116:762–7.
22. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol. 1995;27:104– 9.
23. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, Naito S, Koga H, Saito Y, Nomata K, Kitagawa M, Aso Y. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int. 2002;68:273–80.
24. Toi M, Hirota S, Tomotaki A, Sato N, Hozumi Y, Anan K, Nagashima T, Tokuda Y, Masuda N, Ohsumi S, Ohno S, Takahashi M, Hayashi H, Yamamoto S, Ohashi Y. Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study. Curr Nutr Food Sci. 2013;9:194–200.
25. Bian L, Nagata S, Asahara T, Rahman MS, Ohta T, Yuki N, Wang C, Takano K, Daibo M, Nomoto K, Yamashiro Y. Effects of the continuous intake of Lactobacillus casei strain shirota-fermented milk on risk management of long- term inpatients at health service facilities for the elderly. Int J Probiotics Prebiotics 2011;6:123-32.
26. Fujita R, Iimuro S, Shinozaki T, Sakamaki K, Uemura Y, Takeuchi A, Matsuyama Y, Ohashi Y. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. Am J Infect Control. 2013;41:1231–5.
27. Nagata S, Asahara T, Wang C, Suyama Y, Chonan O, Takano K, Daibou M, Takahashi T, Nomoto K, Yamashiro Y. The effectiveness of Lactobacillus beverages in controlling infections among the residents of an aged care facility: a randomized placebo-controlled double-blind trial. Ann Nutr Metab. 2016;68:51–9.
28. Kato-Kataoka A, Nishida K, Takada M, Kawai M, Kikuchi-Hayakawa H, Suda K, Ishikawa H, Gondo Y, Shimizu K, Matsuki T, Kushiro A, Hoshi R, Watanabe O, Igarashi T, Miyazaki K, Kuwano Y, Rokutan K. Fermented milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl Environ Microbiol. 2016;82:3649–58.
29. Takada M, Nishida K, Kataoka-Kato A, Gondo Y, Ishikawa H, Suda K, Kawai M, Hoshi R, Watanabe O, Igarashi T, Kuwano Y, Miyazaki K, Rokutan K. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil. 2016;28:1027–36.
30. Takada M, Nishida K, Gondo Y, Kikuchi-Hayakawa H, Ishikawa H, Suda K, Kawai M, Hoshi R, Kuwano Y, Miyazaki K, Rokutan K. Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Benef Microbes. 2017;8:153–62.
31. Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr. 2017;8:484–94.
32. Bron PA, Kleerebezem M, Brummer R-J, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J of Nutr. 2017;117:93–107.
33. Sakai T, Oishi K, Asahara T, Takada T, Yuki N, Matsumoto K, Nomoto K, Kushiro A. M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus. Int J Food Microbiol. 2010;139:154–60.
34. Sakai T, Makino H, Ishikawa E, Oishi K, Kushiro A. Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population. Int J Food Sci Nutr 2011;62:423–30.
35. Sakai T, Kubota H, Gawad A, Gheyle L, Ramael S, Oishi K. Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation- related symptoms and haemorrhoids in women during puerperium. Benef Microbes. 2015;6:253-62.
36. Sakai T, Moteki Y, Takahashi T, Shida K, Kiwaki M, Shimakawa Y, Matsui A, Chonan O, Morikawa K, Ohta T, Ohshima H, Furukawa S. Probiotics into outer space: feasibility assessments of encapsulated freeze-dried probiotics during 1 month’s storage on the International Space Station. Sci Rep. 2018;8:10687.
37. Davis C. Enumeration of probiotic strains: Review of culture-dependent and alternative techniques to quantify viable bacteria. J Microbiol Methods. 2014;103:9–17.
38. Asahara T, Shimizu K, Takada T, Kado S, Yuki N, Morotomi M, Tanaka R, Nomoto K. Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice. J Appl Microbiol. 2011;110:163–73.
39. Reid G, Kim SO, Köhler GA. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol Med Microbiol. 2006;46:149–57.
40. Wall R, Fitzgerald G, Hussey S, Ryan T, Murphy B, Ross P, Stanton C. Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and adult gastrointestinal tract. FEMS Microbiol Ecol. 2007;59:127– 37.
41. Nagasaki H, Ito K, Matsuzaki S, Tanaka S. An improved tetrazolium agar medium for testing sugar fermentation in lactobacilli. Nippon Saikingaku Zasshi. 1992;47:511–4.
42. Tharmaraj N, Shah NP. Selective enumeration of Lactobacillus delbrueckii ssp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacteria, Lactobacillus casei, Lactobacillus rhamnosus, and Propionibacteria. J Dairy Sci. 2003;86:2288–96.
43. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B. PASSCLAIM – gut health and immunity. Eur J Nutr. 2004;43 Suppl 2:II118–II173.
44. McCrea GL, Miaskowski C, Stotts NA, Macera L, Hart SA, Varma MG. Review article: self-report measures to evaluate constipation. Aliment Pharmacol Ther. 2008;27:638–48.
45. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut. 1991;32:73–9.
46. Bassotti G, Bellini M, Pucciani F, Bocchini R, Bove A, Alduini P, Battaglia E, Bruzzi P; Italian Constipation Study Group. An extended assessment of bowel habits in a general population. World J Gastroenterol. 2004;10:713–6.
47. Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol. 2004;159:520–6.
48. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 1990;300:439–40.
49. Probert CJ, Emmett PM, Heaton KW. Intestinal transit time in the population calculated from self made observations of defecation. J Epidemiol Community Health. 1993;47:331–3.
50. Degen LP, Phillips SF. How well does stool form reflect colonic transit? Gut. 1996;39:109–13.
51. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–4.
52. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.
53. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology 2016;150:1393–1407.
54. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol. 2003;17:655–9.
55. Kikuchi H, Tajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 1992;60:139–46.
56. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031–64.
57. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes- Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185.
58. Mosele JI, Macià A, Motilva M-J. Metabolic and Microbial Modulation of the Large Intestine Ecosystem by Non-Absorbed Diet Phenolic Compounds: A Review. Molecules. 2015;20:17429–68.
59. De Paula JA, Carmuega E, Weill R. 2008. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam. 2008;38:16–25.
60. Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, Bourdu-Naturel S. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol. 2008;14:6237-6243.
61. Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. Br J Nutr. 2009;102:1654–1662.
62. Kamm M, Mueller-Lissner S, Talley N, Tack J, Boeckxstaens G, Minushkin O, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot S, Nault B. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005;100:362–72.
63. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Eng J Med 2008;358:2344– 2354.
64. Quigley EMM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–328.
65. Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357–365.
66. Chan AO, Lam KF, Hui WM, Hu WH, Li J, Lai KC, Chan CK, Yuen MF, Lam SK, Wong BC. Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population. Aliment Pharmacol Ther. 2005;22:483-8.
67. Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34:870-7.
68. Marquis P, Loge CDL, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005;40:540–51.
69. Seymour CA, Chadwick VS, Liver and gastrointestinal function in pregnancy. Postgraduate Med J. 1979;55:343–352.
70. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern PM. Changes in women’s physical health during the first postpartum year. Arch Fam Med. 1993;2:277–83.
71. Marshall K, Thompson KA, Walsh DM, Baxter GD. Incidence of urinary incontinence and constipation during pregnancy and postpartum: survey of current findings at the Rotunda Lying-in Hospital. BJOG 1998;105:400–402.
72. Saurel‐Cubizolles MJ, Romito P, Lelong N, Ancel PY. Women’s health after childbirth: a longitudinal study in France and Italy. BJOG. 2000;107:1202–9.
73. Bradley CS, Kennedy CM, Turcea AM, Rao SSC, Nygaard IE. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol. 2007;110:1351–1357.
74. Cullen G, O’Donoghue D. Constipation and pregnancy. Best Pract Res Clin Gastroenterol. 2007;21:807–818.
75. Derbyshire EJ, Davies J, Detmar P, Changes in Bowel Function: Pregnancy and the Puerperium. Dig Dis Sci. 2007;52:324–328.
76. Saha S, Manlolo J, McGowan CE, Reinert S, Esposti SD. Gastroenterology Consultations in Pregnancy. J Womens Health. 2011;20:359–363.
77. Loder PB, Kamm MA, Nicholls RJ, Phillips RKS. Haemorrhoids: Pathology, pathophysiology and aetiology. BJS (British Journal of Surgery).1994;81:946–54.
78. Dennison AR, Paraskevopoulos JA, Kerrigan DD, Shorthouse AJ. New thoughts on the aetiology of haemorrhoids and the development of non- operative methods for their management. Minerva Chir. 1996;51:209–16.
79. Abramowitz L, Sobhani I, Benifla JL, Vuagnat A, Daraï E, Mignon M, Madelenat P. Anal fissure and thrombosed external hemorrhoids before and after delivery. Dis Colon Rectum. 2002;45:650–5.
80. Avsar AF, Keskin HL. Haemorrhoids during pregnancy. J Obstetrics Gynaecol. 2010;30:231–7.
81. Hibberts F, Schizas A. Assessment and treatment of patients with haemorrhoids. Nurs Stand. 2010;24:51–6.
82. Liu N, Mao L, Sun X, Liu L, Yao P, Chen B. The effect of health and nutrition education intervention on women’s postpartum beliefs and practices: a randomized controlled trial. BMC Public Health. 2009;9:45.
83. Derbyshire E, Davies J, Costarelli V, Dettmar P. Diet, physical inactivity and the prevalence of constipation throughout and after pregnancy. Matern Child Nutr. 2006;2:127–34.
84. Wanitschke R, Goerg KJ, Loew D. Differential therapy of constipation - a review. Int J Clin Pharmacol Ther. 2003;41:14–21.
85. Tack J, Müller‐Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, Galmiche JP, Fried M. Diagnosis and treatment of chronic constipation – a European perspective. Neurogastroenterol Motil. 2011;23:697-710.
86. Trottier M, Erebara A, Bozzo P. Treating constipation during pregnancy. Can Fam Physician. 2012;58:836-8
87. Shelton MG. Standardized senna in the management of constipation in the puerperium: A clinical trial. S Afr Med J. 1980;57:78–80.
88. O’Boyle AL, O’Boyle JD, Magann EF, Rieg TS, Morrison JC, Davis GD. Anorectal symptoms in pregnancy and the postpartum period. J Reprod Med. 2008;53:151–4.
89. LeBlanc A, Schneider V, Shackelford L, West S, Oganov V, Bakulin A, Voronin L. Bone mineral and lean tissue loss after long duration space flight. J Musculoskelet Neuronal Interact. 2000;1:157-60.
90. Konstantinova IV, Rykova MP, Lesnyak AT, Antropova EA. Immune changes during long-duration missions. J Leukoc Biol. 1993;54:189–201.
91. Rykova MP, Antropova EN, Larina IM, Morukov BV. Humoral and cellular immunity in cosmonauts after the ISS missions. Acta Astronautica. 2008;63:697–705.
92. Crucian BE, Stowe RP, Pierson DL, Sams CF. Immune system dysregulation following short- vs long-duration spaceflight. Aviat Space Environ Med. 2008;79:835–43.
93. Guéguinou N, Huin‐Schohn C, Bascove M, Bueb J-L, Tschirhart E, Legrand‐ Frossi C, Frippiat JP. Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth’s orbit? J Leukoc Biol. 2009;86:1027–38.
94. Stowe RP, Sams CF, Pierson DL. Adrenocortical and immune responses following short- and long-duration spaceflight. Aviat Space Environ Med. 2011;82:627–34.
95. Crucian BE, Zwart SR, Mehta S, Uchakin P, Quiriarte HD, Pierson D, Sams CF, Smith SM. Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight. J Interferon Cytokine Res. 2014;34:778-86.
96. Nagamatsu A, Masukawa M, Kamigaichi S. Development of the space radiation dosimetry system ‛PADLES'. KEK Proc. 2006;2006-7:26-36.
97. Tawara H, Masukawa M, Nagamatsu A, Kitajo K, Kumagai H, Yasuda N. Measurement of a linear energy transfer distribution with antioxidant doped CR-39 correcting for the dip angle dependence of track formation sensitivity. Jpn J Appl Phys. 2008;47:7324–7.
98. Nagamatsu A, Murakami K, Araki S, Kumagai H, Kitajo K, Tawara H. Space radiation dosimetry in low earth orbit by a passive and integrating dosimeter- ‛PADLES'. KEK Proc. 2008;2008-14:167-77.
99. Nagamatsu A, Murakami K, Yokota A, Yamazaki J, Yamauchi M, Kitajo K, Kumagai H, Tawara H. Space radiation damage to HDTV camera CCDs onboard the international space station. Radiation Measurements. 2011;46:205–12.
100. Tawara H, Masukawa M, Nagamatsu A, Kitajo K, Kumagai H, Yasuda N. Characteristics of Mg2SiO4:Tb (TLD-MSO-S) relevant for space radiation dosimetry. Radiation Measurements. 2011;46:709–16.
101. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K, Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004;70:167–73.
102. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int J Food Microbiol. 2008;126:210-5.
103. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR- based RAPD fingerprinting. Nucleic Acids Res. 1992;20:5137–42.
104. Endo A, Okada S. Oenococcus kitaharae sp. nov., a non-acidophilic and non- malolactic-fermenting oenococcus isolated from a composting distilled shochu residue. Int J Syst Evol Microbiol. 2006;56:2345-8.
105. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9.
106. Yasuda E, Serata M, Sako T. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol. 2008;74:4746-55.
107. Wakayama S, Kamada Y, Yamanaka K, Kohda T, Suzuki H, Shimazu T, Tada MN, Osada I, Nagamatsu A, Kamimura S, Nagatomo H, Mizutani E, Ishino F, Yano S, Wakayama T. Healthy offspring from freeze-dried mouse spermatozoa held on the International Space Station for 9 months. Proc Natl Acad Sci USA. 2017;114:5988–93.
108. Thirsk R, Kuipers A, Mukai C, Williams D. The space-flight environment: the International Space Station and beyond. CMAJ. 2009;180:1216–20.
109. Reale M, Boscolo P, Bellante V, Tarantelli C, Nicola MD, Forcella L, Li Q, Morimoto K, Muraro R. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. Br J of Nutr. 2012;108:308–14.
110. Fajardo-Cavazos P, Nicholson WL. Cultivation of Staphylococcus epidermidis in the human spaceflight environment leads to alterations in the frequency and spectrum of spontaneous rifampicin-resistance mutations in the rpoB gene. Front Microbiol. 2016;7:999.
111. Moeller R, Reitz G, Nicholson, the PROTECT Team, Wayne L, Horneck G. Mutagenesis in Bacterial Spores Exposed to Space and Simulated Martian Conditions: Data from the EXPOSE-E Spaceflight Experiment PROTECT. Astrobiology. 2012;12:457–68.
112. Wilson JW, Ott CM, zu Bentrup KH, Ramamurthy R, Quick L, Porwollik S, Cheng P, McClelland M, Tsaprailis G, Radabaugh T, Hunt A, Fernandez D, Richter E, Shah M, Kilcoyne M, Joshi L, Nelman-Gonzalez M, Hing S, Parra M, Dumars P, Norwood K, Bober R, Devich J, Ruggles A, Goulart C, Rupert M, Stodieck L, Stafford P, Catella L, Schurr MJ, Buchanan K, Morici L, McCracken J, Allen P, Baker-Coleman C, Hammond T, Vogel J, Nelson R, Pierson DL, Stefanyshyn-Piper HM, Nickerson CA. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci USA. 2007;104:16299-304.
113. Wilson JW, Ott CM, Quick L, Davis R, zu Bentrup KH, Crabbé A, Richter E, Sarker S, Barrila J, Porwollik S, Cheng P, McClelland M, Tsaprailis G, Radabaugh T, Hunt A, Shah M, Nelman-Gonzalez M, Hing S, Parra M, Dumars P, Norwood K, Bober R, Devich J, Ruggles A, CdeBaca A, Narayan S, Benjamin J, Goulart C, Rupert M, Catella L, Schurr MJ, Buchanan K, Morici L, McCracken J, Porter MD, Pierson DL, Smith SM, Mergeay M, Leys N, Stefanyshyn-Piper HM, Gorie D, Nickerson CA. Media ion composition controls regulatory and virulence response of Salmonella in spaceflight. Ausubel FM, editor. PLoS One. 2008;3:e3923.
114. Kim W, Tengra FK, Young Z, Shong J, Marchand N, Chan HK, Pangule RC, Parra M, Dordick JS, Plawsky JL, Collins CH. Spaceflight promotes biofilm formation by Pseudomonas aeruginosa. PLoS One. 2013;8:e62437.
115. Castro-Wallace S, Stahl S, Voorhies A, Lorenzi H, Douglas GL. Response of Lactobacillus acidophilus ATCC 4356 to low-shear modeled microgravity. Acta Astronautica. 2017;139:463–8.
116. Shao D, Yao L, riaz M shahid, Zhu J, Shi J, Jin M, Huang Q, Yang H. Simulated microgravity affects some biological characteristics of Lactobacillus acidophilus. Appl Microbiol Biotechnol. 2017;101:3439–49.
117. Bourriaud C, Robins RJ, Martin L, Kozlowski F, Tenailleau E, Cherbut C, Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J Appl Microbiol. 2005;99:201–12.
118. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016 03;7:189–200.
119. Chairatana P, Nolan EM. Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut. Crit Rev Biochem Mol Biol. 2017;52:45–56.
120. Nakamura K, Sakuragi N, Takakuwa A, Ayabe T. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health. 2016;35:57–67.
121. Bunker JJ, Bendelac A. IgA Responses to Microbiota. Immunity. 2018 21;49:211–24.
122. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–7.